Rabinowits G, Homsi J, Park S, Khushalani N, Panella T, Ellison D, Gentry R, Venna S, Strasswimmer J, Zuniga R, Chandra S, Ruiz E, Migden M, Ibrahim S, Mehta N, Inocencio T, He X, Zhang H, Gillis K, Pouliot J-F. CemiplimAb-rwlc Survivorship and Epidemiology (CASE): A prospective study of the safety and efficacy of cemiplimab in patients with advanced cutaneous squamous cell carcinoma (CSCC) in a real-world setting. J of Skin [Internet]. 2023Mar.13 [cited 2024Jul.22];7(2):s174. Available from: https://jofskin.org/index.php/skin/article/view/1998